content

AbbVie to Present New Analyses from Pivotal Phase 3 Studies for RINVOQ in Atopic Dermatitis

AbbVie at the 29th European Academy of Dermatology and Venereology (EADV) Virtual Congress show that significantly more atopic dermatitis patients treated with upadacitinib (15...

Baxter Supports New Study Showing Blood Purification with Oxiris Filter Set Can Play a Role in the Management of Severely Ill COVID-19 Patients

Baxter International Inc., a global leader in acute care, recognizes the findings of a prospective, multicenter, observational study on data from the OxirisNet Registry...

Sanofi, GSK to support COVAX with 200mn doses of Covid-19 vaccine

Sanofi and GSK have signed a Statement of Intent with Gavi, the legal administrator of the COVAX Facility, a global risk-sharing mechanism for pooled...

TurboFil Introduces Module for Simplified, Automated Syringe Filling & Assembly

Company’s SimpliFil Syringe Filling & Assembly System incorporates efficient, through-the-tip filling process for reliable and cost-effective handling of small to medium syringe batches. TurboFil Packaging...

Schreiner MediPharm Equips Cap-Lock Security Label with RFID Technology

Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the healthcare industry, has enhanced its tamper-evident specialty label, Cap-Lock, with a...

Cipla launches ‘ELIFast’ (IgG ELISA test) for COVID-19 antibody detection

Cipla Limited announced the commercialisation of antibody detection kits for COVID-19 in India. In partnership with KARWA Ltd. under the technology transfer from the...

Catalent to Acquire Cell Therapy Manufacturing Facility from Bone Therapeutics

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, ...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read